B
Beam Therapeutics
Cambridge, United States
Founded 2017 NASDAQ: BEAM
Gene Therapy Delivery DNA Nanotechnology Protein Engineering Nano-Bio Nanomedicine Synthetic Biology
About
Pioneer in base editing using lipid nanoparticle delivery for precision genetic medicines
Company Details
- Type
- commercial
- Employees
- 500-1000
- Funding
- Public
Key Products
- BEAM-101
- Base Editing Platform